Thyroid Cancer | Tumor

CURE’s thyroid cancer page is an extensive resource of cancer information featuring the latest thyroid cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on thyroid cancer.

Blowing a Fuse: Fighting NTRK Gene Fusions in Cancer

August 30th 2019, 12:00am

Article

A new drug can break the circuit of cancer-causing effects that develop when certain genes fuse.

Cancer: It's Never An Easy Journey

July 2nd 2019, 6:00pm

Article

Cancer doesn’t discriminate. It doesn’t care what race, gender, ethnicity, sexuality or even age you are. It takes no prisoners. And it certainly did not take me. I continue to remain resilient despite what I’ve been through and despite what still may be on the horizon.

Friday Frontline: June 7, 2019

June 7th 2019, 10:00pm

Article

From today’s top entertainers to racial disparities in access to pain treatment, here’s what is making headlines in the cancer space this week.

Diagnosed, Not Defeated

May 23rd 2019, 12:21am

Article

As a result of what I went through and my never-ending passion for helping others, I believe that my diagnosis happened for a reason – to lead me to a career in patient advocacy.

Medullary and Anaplastic Thyroid Cancer

April 19th 2019, 6:21pm

Article

Sweet Serendipity: Cancer Caught on Television

November 27th 2018, 8:46pm

Article

Survivor diagnosed with second cancer after surgeon spots a lump on her throat while watching TV.

LOXO-292 Granted Breakthrough Designation for Thyroid Cancer

October 15th 2018, 7:06pm

Article

The Food and Drug Administration has granted LOXO-292 a breakthrough therapy designation for the treatment of patients with advanced RET fusion–positive thyroid cancer who require systemic therapy, have progressed on prior treatment, and have no other acceptable alternative treatment options, according to a statement from Loxo Oncology, the developer of the selective RET inhibitor.

LOXO-292 Granted Breakthrough Therapy Designation for Lung and Thyroid Cancer

September 5th 2018, 9:37pm

Article

The FDA has granted LOXO-292 a breakthrough therapy designation for the treatment of patients with RET fusion–positive non–small cell lung cancer (NSCLC) or RET-mutant medullary thyroid cancer (MTC). This designation will expedite the development and review of the drug.

Searching for Understanding About RAS Mutations but Capitalizing on What We Know

August 16th 2018, 5:29pm

Article

From genetic mutations to treatment behind bars, here's a roundup of our 2018 Summer issue.

Saved by the TV Screen

August 9th 2018, 4:00pm

Podcast

In this week’s episode of CURE Talks Cancer, we spoke with Voigt about how he noticed a lump in a woman’s neck while watching tv and utilized the power of social media to find her – which ultimately led to a thyroid cancer diagnosis.